Keywords: nice, rejects, erbitux, latest, cancer, indication, national

NICE rejects Erbitux for latest cancer indication

Article | 12 February 2007

Print This

The National Institute for Health and Clinical Excellence (NICE), the UK advisory body responsible for evaluating the effectiveness of drugs ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in